Generics of MSD diabetes pill set to flood market as patent expires

According to market research firm AIOCD, at least 50 Indian drug makers are jumping into the fray with around 100 generic versions of the popular anti-diabetes medication, leading to a likely price war.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/cveV1Jd
via IFTTT